Paige Announces Collaboration to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings
Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds Goal is to provide physicians with important insights to help tailor patients’ treatment plans and facilitate clinical trial recruitment NEW YORK–(BUSINESS WIRE)–Paige, a global leader in clinical AI applications … [Read more…]
